135 related articles for article (PubMed ID: 23316474)
1. Radiation therapy quality in CCG/POG intergroup 9961: implications for craniospinal irradiation and the posterior fossa boost in future medulloblastoma trials.
Donahue B; Marymont MA; Kessel S; Iandoli MK; Fitzgerald T; Holmes E; Kocak M; Boyett JM; Gajjar A; Packer RJ
Front Oncol; 2012; 2():185. PubMed ID: 23316474
[TBL] [Abstract][Full Text] [Related]
2. Patterns of failure following treatment for medulloblastoma: is it necessary to treat the entire posterior fossa?
Fukunaga-Johnson N; Lee JH; Sandler HM; Robertson P; McNeil E; Goldwein JW
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):143-6. PubMed ID: 9747831
[TBL] [Abstract][Full Text] [Related]
3. Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastoma.
Taylor RE; Bailey CC; Robinson KJ; Weston CL; Ellison D; Ironside J; Lucraft H; Gilbertson R; Tait DM; Saran F; Walker DA; Pizer BL; Lashford LS; ;
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1184-93. PubMed ID: 15001263
[TBL] [Abstract][Full Text] [Related]
4. Vulnerability of white matter to insult during childhood: evidence from patients treated for medulloblastoma.
Moxon-Emre I; Bouffet E; Taylor MD; Laperriere N; Sharpe MB; Laughlin S; Bartels U; Scantlebury N; Law N; Malkin D; Skocic J; Richard L; Mabbott DJ
J Neurosurg Pediatr; 2016 Jul; 18(1):29-40. PubMed ID: 27015518
[TBL] [Abstract][Full Text] [Related]
5. An Analysis of Major Target Deviations in Craniospinal Irradiation Treatment Plans for Patients With Intermediate-Risk Medulloblastoma Within a Phase 3 Clinical Trial (Children's Oncology Group Study ACNS0331).
Schiff JP; Lee Y; Wang Y; Perkins SM; Kessel SK; Fitzgerald TJ; Larrier NA; Michalski JM
Adv Radiat Oncol; 2023; 8(1):101083. PubMed ID: 36483060
[TBL] [Abstract][Full Text] [Related]
6. Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma.
Merchant TE; Kun LE; Krasin MJ; Wallace D; Chintagumpala MM; Woo SY; Ashley DM; Sexton M; Kellie SJ; Ahern V; Gajjar A
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):782-7. PubMed ID: 17892918
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment central quality control for craniospinal irradiation in non-metastatic medulloblastoma : First experiences of the German radiotherapy quality control panel in the SIOP PNET5 MB trial.
Dietzsch S; Braesigk A; Seidel C; Remmele J; Kitzing R; Schlender T; Mynarek M; Geismar D; Jablonska K; Schwarz R; Pazos M; Walser M; Frick S; Gurtner K; Matuschek C; Harrabi SB; Glück A; Lewitzki V; Dieckmann K; Benesch M; Gerber NU; Rutkowski S; Timmermann B; Kortmann RD
Strahlenther Onkol; 2021 Aug; 197(8):674-682. PubMed ID: 33226469
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy in pediatric medulloblastoma: quality assessment of Pediatric Oncology Group Trial 9031.
Miralbell R; Fitzgerald TJ; Laurie F; Kessel S; Glicksman A; Friedman HS; Urie M; Kepner JL; Zhou T; Chen Z; Barnes P; Kun L; Tarbell NJ
Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1325-30. PubMed ID: 16413699
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of the relationship between the quality of prophylactic cranial radiotherapy in childhood acute leukemia and institutional experience: a Quality Assurance Review Center-Pediatric Oncology Group study.
Halperin EC; Laurie F; Fitzgerald TJ
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):1001-4. PubMed ID: 12095569
[TBL] [Abstract][Full Text] [Related]
10. Reduced-volume tumor-bed boost is not associated with inferior local control and survival outcomes in high-risk medulloblastoma.
Tian S; Sudmeier LJ; Zhang C; Madden NA; Buchwald ZS; Shu HG; Curran WJ; Eaton BR; Esiashvili N
Pediatr Blood Cancer; 2020 Jan; 67(1):e28027. PubMed ID: 31571408
[TBL] [Abstract][Full Text] [Related]
11. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques?
Lee CT; Bilton SD; Famiglietti RM; Riley BA; Mahajan A; Chang EL; Maor MH; Woo SY; Cox JD; Smith AR
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):362-72. PubMed ID: 16168831
[TBL] [Abstract][Full Text] [Related]
12. Impact of targeting deviations on outcome in medulloblastoma: study of the French Society of Pediatric Oncology (SFOP).
Carrie C; Hoffstetter S; Gomez F; Moncho V; Doz F; Alapetite C; Murraciole X; Maire JP; Benhassel M; Chapet S; Quetin P; Kolodie H; Lagrange JL; Cuillere JC; Habrand JL
Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):435-9. PubMed ID: 10487567
[TBL] [Abstract][Full Text] [Related]
13. Survival of very young children with medulloblastoma (primitive neuroectodermal tumor of the posterior fossa) treated with craniospinal irradiation.
Saran FH; Driever PH; Thilmann C; Mose S; Wilson P; Sharpe G; Adamietz IA; Böttcher HD
Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):959-67. PubMed ID: 9869216
[TBL] [Abstract][Full Text] [Related]
14. Exclusive Hyperfractionated Radiation Therapy and Reduced Boost Volume for Standard-Risk Medulloblastoma: Pooled Analysis of the 2 French Multicentric Studies MSFOP98 and MSFOP 2007 and Correlation With Molecular Subgroups.
Carrie C; Kieffer V; Figarella-Branger D; Masliah-Planchon J; Bolle S; Bernier V; Laprie A; Supiot S; Leseur J; Habrand JL; Alapetite C; Kerr C; Dufour C; Claude L; Chapet S; Huchet A; Bondiau PY; Escande A; Truc G; Nguyen TD; Pasteuris C; Vigneron C; Muracciole X; Bourdeaut F; Appay R; Dubray B; Colin C; Ferlay C; Dussart S; Chabaud S; Padovani L; ;
Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1204-1217. PubMed ID: 32768563
[TBL] [Abstract][Full Text] [Related]
15. Osteopenia in children who have undergone posterior fossa or craniospinal irradiation for brain tumors.
Krishnamoorthy P; Freeman C; Bernstein ML; Lawrence S; Rodd C
Arch Pediatr Adolesc Med; 2004 May; 158(5):491-6. PubMed ID: 15123484
[TBL] [Abstract][Full Text] [Related]
16. Updated results of a pilot study of low dose craniospinal irradiation plus chemotherapy for children under five with cerebellar primitive neuroectodermal tumors (medulloblastoma).
Goldwein JW; Radcliffe J; Johnson J; Moshang T; Packer RJ; Sutton LN; Rorke LB; D'Angio GJ
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):899-904. PubMed ID: 8598368
[TBL] [Abstract][Full Text] [Related]
17. Clinical Outcomes Among Children With Standard-Risk Medulloblastoma Treated With Proton and Photon Radiation Therapy: A Comparison of Disease Control and Overall Survival.
Eaton BR; Esiashvili N; Kim S; Weyman EA; Thornton LT; Mazewski C; MacDonald T; Ebb D; MacDonald SM; Tarbell NJ; Yock TI
Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):133-138. PubMed ID: 26700707
[TBL] [Abstract][Full Text] [Related]
18. HIT '91 (prospective, co-operative study for the treatment of malignant brain tumors in childhood): accuracy and acute toxicity of the irradiation of the craniospinal axis. Results of the quality assurance program.
Kortmann RD; Timmermann B; Kühl J; Willich N; Flentje M; Meisner C; Bamberg M
Strahlenther Onkol; 1999 Apr; 175(4):162-9. PubMed ID: 10230458
[TBL] [Abstract][Full Text] [Related]
19. Reducing late effects of radiotherapy in average risk medulloblastoma.
Ibrahim NY; Abdel Aal HH; Abdel Kader MS; Makaar WS; Shaaban AH
Chin Clin Oncol; 2014 Mar; 3(1):4. PubMed ID: 25842082
[TBL] [Abstract][Full Text] [Related]
20. Medulloblastoma and supratentorial primitive neuroectodermal tumors: an institutional experience.
Paulino AC; Melian E
Cancer; 1999 Jul; 86(1):142-8. PubMed ID: 10391574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
